Global /South Korea /Healthcare /Medical Devices /084650

LabGenomics Co., Ltd.

084650

• KRX: 084650 • Delayed

1,328KRW -2.9%

0.8701 USD

As of 13 June 2026, LabGenomics Co., Ltd. has a market cap of $66.78M USD, ranking #28433 globally and #1512 in South Korea. It ranks #2574 in the Healthcare sector, and #526 in the Medical Devices industry.

Global Rank

28433

Country Rank

1512

Sector Rank

2574

Industry Rank

526

Key Stats

Market Cap

$66.78MUSD

101.56B KRW

Enterprise Value

$64.89MUSD

99.04B KRW

Revenue (TTM)

$57.97MUSD

88.16B KRW

EBITDA (TTM)

-$29.23MUSD

-44.61B KRW

Net Income (TTM)

-$42.33MUSD

-64.37B KRW

EBITDA Margin

-51%

Profit Margin

-73%

PS Ratio

1.2

PB Ratio

0.7

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

Sung Chin open_in_new

Employees

142

Founded

2002

Website

labgenomics.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.9%	-8.4%	1.1%	-24%	-45%	-24%	-37%	-54%	-68%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	084650 (주)랩지노믹스 ISIN: KR7084650001 Shares Out.: Shares Outstanding: 74.24M¹ Shares Float: 57.953M² TV: TradingView: KRX: 084650 SA: Stock Analysis: KRX: 084650 YF: Yahoo Finance: 084650.KS GF: Google Finance: KRX: 084650 BA: Barron's: 084650 MS: Morningstar: XKRX: 084650	1,328 KRW	TV: TradingView: KRX: 084650 SA: Stock Analysis: KRX: 084650 YF: Yahoo Finance: 084650.KS GF: Google Finance: KRX: 084650 BA: Barron's: 084650 MS: Morningstar: XKRX: 084650

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About LabGenomics Co., Ltd.

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.47B 3.75T KRW 4K%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.23B 1.86T KRW 2K%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.19B 1.81T KRW 2K%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.14B 1.74T KRW 2K%	-	South Korea
Seegene, Inc. KRX: 096530	$759.58M 1.16T KRW 1K%	23.9	South Korea
i3system Inc. KRX: 214430	$532.37M 809.64B KRW 697%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 259K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 241K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 238K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 189K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 181K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 152K%	22.2	Ireland

chevron_leftBack